Floatz logo

Therapeutic Asset Ratings

188 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
TRASTUZUMAB
Pancreatic Cancer
Cancer Research UKP2/3B (59)
Dabrafenib
Solid Tumor
Cancer Research UKP4B (58)
Entrectinib
Solid Tumor
Cancer Research UKP2/3B (58)
ALECTINIB
Advanced Cancer
Cancer Research UKP2/3B (57)
ALECTINIB
Lymphoproliferative Disorders
Cancer Research UKP2/3B (57)
ALECTINIB
Solid Tumour
Cancer Research UKP2/3B (57)
Atezolizumab
Lymphoproliferative Disorders
Cancer Research UKP2/3B (57)
Entrectinib
Brain Neoplasms
Cancer Research UKP2/3B (57)
Entrectinib
Lymphoproliferative Disorders
Cancer Research UKP2/3B (57)
Entrectinib
Solid Tumour
Cancer Research UKP2/3B (57)
gsk1120212
Glioma
Cancer Research UKP2/3B (57)
gsk1120212
Multiple Myeloma
Cancer Research UKP2/3B (57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Gallbladder Neoplasms
Cancer Research UKP2/3B (57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Lung Neoplasm
Cancer Research UKP2/3B (57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Prostatic Neoplasm
Cancer Research UKP2/3B (57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Salivary Gland Neoplasm
Cancer Research UKP2/3B (57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Skin Neoplasm
Cancer Research UKP2/3B (57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Urinary Bladder Neoplasm
Cancer Research UKP2/3B (57)
TRASTUZUMAB
Ovarian Neoplasms
Cancer Research UKP2/3B (57)
TRASTUZUMAB
Prostatic Neoplasm
Cancer Research UKP2/3B (57)
TRASTUZUMAB
Salivary Gland Neoplasm
Cancer Research UKP2/3B (57)
TRASTUZUMAB
Skin Neoplasm
Cancer Research UKP2/3B (57)
TRASTUZUMAB
Urinary Bladder Neoplasm
Cancer Research UKP2/3B (57)
Cobimetinib
Erdheim-Chester Disease
Cancer Research UKP2/3B (56)
Cobimetinib
Laryngeal Neoplasms
Cancer Research UKP2/3B (56)
Showing 26 to 50 of 188 assets
PreviousPage 2 of 8Next